业界动态监管公开信息 · FDA
作为药物批准或许可依据的替代终点表
FDA Drugs · 2026-10-30 01:29
摘要
FDA的替代终点表为药物开发者提供了有价值的信息，说明了在个体开发项目中可考虑并与FDA讨论的终点。
English
Table of Surrogate Endpoints That Were the Basis of Drug Approval or Licensure
FDA’s surrogate endpoint table provides valuable information for drug developers on endpoints that may be considered and discussed with FDA for individual development programs.